دورية أكاديمية

955P IMMUNIB trial (AIO-HEP-0218/ass): A single-arm phase II study evaluating safety and efficacy of immunotherapy with nivolumab in combination with lenvatinib in advanced hepatocellular carcinoma

التفاصيل البيبلوغرافية
العنوان: 955P IMMUNIB trial (AIO-HEP-0218/ass): A single-arm phase II study evaluating safety and efficacy of immunotherapy with nivolumab in combination with lenvatinib in advanced hepatocellular carcinoma
المؤلفون: Vogel, A., Saborowski, A., Siegler, G.M., Siebler, J., Lindig, U., Schultheiss, M., Mueller, T., Simon, H., Jöckel, C., Müller, D.W., Al-Batran, S-E., De Toni, E.
المصدر: In Annals of Oncology October 2023 34 Supplement 2:S598-S598
قاعدة البيانات: ScienceDirect
الوصف
تدمد:09237534
DOI:10.1016/j.annonc.2023.09.2101